Follow
Richard Gray
Richard Gray
The Kirby Institute, University of New South Wales, Sydney Australia
Verified email at kirby.unsw.edu.au
Title
Cited by
Cited by
Year
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
14492018
HIV, viral hepatitis and sexually transmissible infections in Australia
S McGregor, H McManus, R Gray
The Kirby Institute, 2016
4242016
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
2712022
Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization
CC Kerr, RM Stuart, RT Gray, AJ Shattock, N Fraser-Hurt, C Benedikt, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (3), 365-376, 2015
1202015
Frequent testing of highly sexually active gay men is required to control syphilis
RT Gray, A Hoare, GP Prestage, B Donovan, JM Kaldor, DP Wilson
Sexually transmitted diseases, 298-305, 2010
1132010
Mean-field modeling of the basal ganglia-thalamocortical system. II: dynamics of parkinsonian oscillations
SJ van Albada, RT Gray, PM Drysdale, PA Robinson
Journal of theoretical biology 257 (4), 664-688, 2009
1112009
The potential impact of vaccination on the prevalence of gonorrhea
AP Craig, RT Gray, JL Edwards, MA Apicella, MP Jennings, DP Wilson, ...
Vaccine 33 (36), 4520-4525, 2015
962015
Modeling the Impact of Potential Vaccines on Epidemics of Sexually Transmitted Chlamydia trachomatis Infection
RT Gray, KW Beagley, P Timms, DP Wilson
The Journal of infectious diseases 199 (11), 1680-1688, 2009
922009
Increased HIV testing will modestly reduce HIV incidence among gay men in NSW and would be acceptable if HIV testing becomes convenient
RT Gray, GP Prestage, I Down, MH Ghaus, A Hoare, J Bradley, DP Wilson
PloS one 8 (2), e55449, 2013
882013
Chronic hepatitis C burden and care cascade in Australia in the era of interferon‐based treatment
B Hajarizadeh, J Grebely, H McManus, C Estes, H Razavi, RT Gray, ...
Journal of gastroenterology and hepatology 32 (1), 229-236, 2017
862017
A cost-effectiveness analysis of HIV preexposure prophylaxis for men who have sex with men in Australia
K Schneider, RT Gray, DP Wilson
Clinical infectious diseases 58 (7), 1027-1034, 2014
832014
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study
JA Kwon, GJ Dore, J Grebely, B Hajarizadeh, R Guy, EB Cunningham, ...
Journal of viral hepatitis 26 (1), 83-92, 2019
742019
Dynamical reconnection and stability constraints on cortical network architecture
PA Robinson, JA Henderson, E Matar, P Riley, RT Gray
Physical review letters 103 (10), 108104, 2009
692009
Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models
D Keebler, P Revill, S Braithwaite, A Phillips, N Blaser, A Borquez, ...
The Lancet Global Health 2 (1), e35-e43, 2014
672014
The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS
SL Kelly, R Martin-Hughes, RM Stuart, XF Yap, DJ Kedziora, ...
The lancet HIV 5 (4), e190-e198, 2018
492018
Estimating the number of people who inject drugs in Australia
S Larney, M Hickman, R Guy, J Grebely, GJ Dore, RT Gray, CA Day, ...
BMC public health 17 (1), 1-7, 2017
492017
Chemoprophylaxis is likely to be acceptable and could mitigate syphilis epidemics among populations of gay men
DP Wilson, GP Prestage, RT Gray, A Hoare, P McCann, I Down, RJ Guy, ...
Sexually transmitted diseases, 573-579, 2011
462011
How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries
RM Stuart, L Grobicki, H Haghparast‐Bidgoli, J Panovska‐Griffiths, ...
Journal of the International AIDS Society 21 (4), e25097, 2018
332018
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ...
The Lancet Gastroenterology & Hepatology 8 (10), 879-907, 2023
322023
The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90‐90‐90 targets
P Keen, RT Gray, B Telfer, R Guy, HM Schmidt, B Whittaker, J Holden, ...
Journal of the International AIDS Society 21 (4), e25109, 2018
322018
The system can't perform the operation now. Try again later.
Articles 1–20